Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02810457
Title	Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer (AVANA)
Acronym	AVANA
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Centus Biotherapeutics Limited
Indications	lung non-squamous non-small cell carcinoma
Therapies	Carboplatin + FKB238 + Paclitaxel Bevacizumab + Carboplatin + Paclitaxel
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| ROU \| POL \| ITA \| HUN \| HRV \| GRC \| ESP \| DEU \| BGR